GALMED PHARMACEUTICALS LTD. Total Liabilities and Equity
GALMED PHARMACEUTICALS LTD. (GLMD) had Total Liabilities and Equity of $18.28 million as of 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-09-02
- 2026-06-30: Liabilities and Equity $18.28M.
- 2025-12-31: Liabilities and Equity $18.63M.
- 2025-09-30: Liabilities and Equity $21.58M.
- 2025-06-30: Liabilities and Equity $22.94M.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $18.28M 6-K · filed 2026-09-02 |
| 2025-12-31 | $18.63M 6-K · filed 2026-09-02 |
| 2025-09-30 | $21.58M 6-K · filed 2025-11-26 |
| 2025-06-30 | $22.94M 6-K · filed 2025-08-28 |
| 2024-12-31 | $18.50M 20-F · filed 2026-03-31 |
| 2024-06-30 | $13.34M 6-K · filed 2024-08-28 |
| 2023-12-31 | $16.63M 20-F · filed 2025-04-02 |
| 2023-06-30 | $13.28M 6-K · filed 2023-08-09 |
| 2022-12-31 | $16.56M 20-F · filed 2024-04-04 |
| 2022-06-30 | $23.57M 6-K · filed 2022-08-04 |
| 2021-12-31 | $36.60M 20-F · filed 2023-03-29 |
| 2021-06-30 | $52.33M 6-K · filed 2021-08-05 |
| 2020-12-31 | $52.38M 20-F · filed 2022-05-02 |
| 2020-06-30 | $64.85M 6-K · filed 2020-08-06 |
| 2019-12-31 | $77.14M 20-F · filed 2021-03-18 |
| 2019-06-30 | $85.11M 6-K · filed 2019-08-05 |
| 2018-12-31 | $90.60M 20-F · filed 2020-03-12 |
| 2018-06-30 | $94.85M 6-K · filed 2018-08-02 |
| 2017-12-31 | $19.64M 20-F · filed 2019-03-13 |
| 2017-06-30 | $10.03M 6-K · filed 2017-07-31 |
| 2016-12-31 | $16.45M 20-F · filed 2018-03-13 |
| 2016-06-30 | $18.00M 6-K · filed 2017-06-23 |
| 2015-12-31 | $24.26M 6-K · filed 2017-06-23 |
| 2014-12-31 | $32.92M 20-F · filed 2016-03-22 |
| 2013-12-31 | $166.00K 20-F · filed 2015-03-31 |